
DLinDMA
CAS No. 871258-12-7
DLinDMA( —— )
Catalog No. M24885 CAS No. 871258-12-7
DLinDMA, as a benchmark, is a key stable nucleic acid lipid particleslipid component.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
25MG | 53 | In Stock |
![]() ![]() |
50MG | 77 | In Stock |
![]() ![]() |
100MG | 114 | In Stock |
![]() ![]() |
200MG | 172 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameDLinDMA
-
NoteResearch use only, not for human use.
-
Brief DescriptionDLinDMA, as a benchmark, is a key stable nucleic acid lipid particleslipid component.
-
DescriptionDLinDMA, as a benchmark, is a key stable nucleic acid lipid particleslipid component.
-
In VitroThe structure of DLinDMA can be divided into three main regions: the hydrocarbon chains, the linker and the headgroup.
-
In VivoDLinDMA has virtually indistinguishable blood pharmacokinetic profiles in mice.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number871258-12-7
-
Formula Weight616.06
-
Molecular FormulaC41H77NO2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 100 mg/mL (162.32 mM);DMSO: < 1 mg/mL (insoluble or slightly soluble)
-
SMILESCCCCC/C=C\C/C=C\CCCCCCCCOCC(OCCCCCCCC/C=C\C/C=C\CCCCC)CN(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Semple SC, et al. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol. 2010 Feb;28(2):172-6.
molnova catalog



related products
-
Ilexoside XLVIII
Ilexoside XLVIII is an acyl CoA cholesteryl acyl transferase ( ACAT ) inhibitor. Ilexoside XLVIII is a triterpene saponin isolated from an aqueous extract of the leaves of Ilex kudincha.
-
Formononetin
Formononetin is a phytoestrogen from the root of Astragalus membranaceus and an O-methylated isoflavone.
-
ACT-389949
ACT-389949 is a potent and selective agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes.